Comparison of FIA and on-column LC-MS/MS method to measure simultaneously ABG, ASM, GAA, GALC, GLA and IDUA activities

Similar documents
The Effects of Low Birth Weight on the Newborn Screening Activities of Enzymes Associated with Lysosomal Storage Disorders

High Throughput simultaneous analysis of 39 amino acids in various foods without derivatization using LC-MS/MS

Neonatal Screening for Lysosomal Storage Disorders (LSD) by Tandem Mass Spectrometry (MSMS)

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Integration of steroids analysis in serum using LC-MS/MS with full-automated sample preparation

Vitamin D3 and related compounds by ESI and APCI

Highly sensitive simultaneous quantitative analysis of estrone and equilin from plasma using LC/MS/MS

Fully automated sensitive determination of immunosuppressant drugs in whole blood, using high quality internal standardization

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

KJLM. Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population INTRODUCTION

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Determination of Amantadine Residues in Chicken by LCMS-8040

LSD EASY AND EFFICIENT SCREENING. NeoLSD MSMS kit

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Unique Retention and Selectivity of Pentafluorophenylpropyl Phases for High-Throughput LC/MS Analysis

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Exploring Changes in Primary Metabolites in Alzheimer s Disease using Targeted LC-MS/MS

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Comprehensive Two-Dimensional HPLC and Informative Data Processing for Pharmaceuticals and Lipids

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Automated Targeted screening of Benzodiazepines in urine using LDTD-MS/MS at 400 samples per hour rate

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Dienes Derivatization MaxSpec Kit

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Supporting Information

Author. Introduction. Abstract

Fully Automated Online Sample Preparation AND Quantification of Amiodarone from Whole Blood using CLAM-LC-MS/MS

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

PosterREPRINT SIMULTANEOUS QUANTIFICATION OF PSYCHOTHERAPEUTIC DRUGS IN HUMAN PLASMA BY TANDEM MASS SPECTROMETRY

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Uptake and Metabolism of Phthalate Esters by Edible Plants

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Separation and Quantitation of Oxysterol Compounds Using LC-MS/MS. Liquid Chromatography Mass Spectrometry SSI-LCMS-082

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

Neosolaniol. [Methods listed in the Feed Analysis Standards]

[ APPLICATION NOTE ] A Generic Kit-Based Approach for LC-MS/MS Quantification of Urinary Albumin for Clinical Research APPLICATION BENEFITS

Detection of Cotinine and 3- hydroxycotine in Smokers Urine

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

A Novel Platform of On-line Sample Pre-treatment and LC/MS/MS Analysis for Screening and Quantitation of Illicit Drugs in Urine

Measuring Lipid Composition LC-MS/MS

SUPPORTING INFORMATION FOR: CONCENTRATIONS OF POLYBROMINATED DIPHENYL ETHERS, HEXABROMOCYCLODODECANES AND TETRABROMOBISPHENOL-A IN BREAST MILK FROM

Abstract. Introduction

LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column

Supplementary Information. Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse by a

Determination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety

Fig. 1: Chemical structure of arachidonic acid COOH CH 3

Neonatal Screening using Shimadzu LCMS-8040

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Phospholipid characterization by a TQ-MS data based identification scheme

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Oxysterol, Secosterols, and Cholesterol Intermediates Separation and Quantitation Using Triple Quadrupole Mass Spectrometry

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Comparison of Methods for the Analysis of Lysosomal Enzyme Activities in Quality Control Dried Blood Spot Specimens

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

Designer Cannabinoids

Quantitation of Protein Phosphorylation Using Multiple Reaction Monitoring

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Neonatal Screening using Shimadzu LCMS- 8040

Methods and Materials

Determination of red blood cell fatty acid profiles in clinical research

application Natural Food Colorants Analysis of Natural Food Colorants by Electrospray and Atmospheric Pressure Chemical Ionization LC/MS

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

LC/MS Method for Comprehensive Analysis of Plasma Lipids

AbsoluteIDQ p150 Kit. Targeted Metabolite Identifi cation and Quantifi cation. Bringing our targeted metabolomics expertise to your lab.

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Offline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research

Determination of Clarithromycin in Human Plasma by LC-EI Tandem Mass Spectrometry: Application to Bioequivalence Study

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

APPLICATIONS TN Analytical Method

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Simultaneous Analysis of Amino Acids and Acylcarnitines in Dried Blood Spots

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

for the Identification of Phosphorylated Peptides

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

A Tandem Mass Spectrometry Triplex Assay for the Detection of Fabry, Pompe, and Mucopolysaccharidosis-I (Hurler)

Step 3: muscle, nasal sprays and drops or used as topical

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Application Note. Abstract. Authors. Pharmaceutical

Simultaneous Analysis of Intact Human Insulin and Five Analogs in Human Plasma Using μelution SPE and a CORTECS UPLC Column

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Application Note. Author. Abstract. Introduction. Food Safety

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Supporting information

Dry eye disease commonly known as atopic keratoconjunctivitis is an autoimmune disease of

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

PHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES. DR. A. RAMESH, Ph.D, D.Sc.,

Identification of Ginsenosides Using the SCIEX X500R QTOF System

Transcription:

O-CON1718E Comparison of FIA and on-column LC-M/M method to measure simultaneously ABG, AM, GAA, GALC, GLA and IDUA activities AM 2017 Th 091 Misa Tanaka, Jun Watanabe, Toshikazu Minohata, Junichi Masuda, Eishi Imoto himadzu Corporation. 1, Nishinokyo-Kuwabaracho Nakagyo-ku, Kyoto 604-8511, JAAN

Introduction Lysosome is a membrane-enclosed organelle and contains hydrolytic enzymes. They can digest virtually all kinds of biomolecules. ome techniques such as fluorometric and spectrophotometric assays have been developed to measure these enzyme activities. Multiplex flow injection analysis using tandem mass spectrometry (FIA-M/M) method has been developed that simultaneously measures the activities of the enzymes, alphaglucocerebrosidase (ABG), sphingomyelinase (AM), alpha-glucosidase (GAA), galactocerebrosidase (GALC), alpha-galactosidase A (GLA) and alpha-iduronidase (IDUA). The use of mass spectrometric techniques has exhibited advantages over the other techniques in the simultaneous quantification of several targets. However, FIA-M/M method can exhibit background noise levels that lead to inaccurate data interpretation. Here we compared and evaluated FIA LC-M/M method and on-column LC-M/M method to simultaneously measure these enzyme activities. Methods and Materials 6-plex NeoLD reagent (erkinelmer Inc.) was used for this study. This kit contains assay buffer, substrates for 6 enzymes and internal standards. 3.2 mm diameter disks were punched from the DBs and placed in a 96-well plate. Assays were run according to the procedure of the kit with overnight incubation (16-20 hours). ABG products AM ABG ABG substrate (ABG-) AM substrate (AM-) GAA GALC GAA substrate (GAA-) GALC substrate (AM-) GLA IDUA GLA substrate (GAA-) IDUA substrate (GAA-) Figure 1 6 substrates for 6 enzymes; I are deuterated forms of enzyme products 2

Figure 2 6-plex NeoLD reagent workflow Flow injection analysis (FIA) and on-column analysis were achieved using LC-M/M system; UHLC was coupled to triple quadrupole mass spectrometer (Nexera with LCM-8050, himadzu Corporation, Kyoto, Japan). The mobile phase consisted of (A) water + 0.1 % formic acid and (B) Acetonitrile + 0.1 % formic acid. LC-M/M with electrospray ionization was operated in multiple-reaction-monitoring (MRM) mode. Analytical Conditions HLC conditions (Nexera M system) Flow Injection Analysis Mobile phase : A: water + 0.1 % formic acid B: Acetonitrile + 0.1 % formic acid Isocratic Flow : B 84 % Flow rate : 0.3 ml/min Injection volume : 10 μl On Column Analysis Mobile phase : A: water + 0.1 % formic acid B: Acetonitrile + 0.1 % formic acid Flow rate : 0.2 ml/min Injection volume : 1 μl Column : GL ciences MonoTower C18 100 mm (3.0 um x 50 mm x 2 pieces) Time program : 0 min. B 75 % > 2 min. B 75% > 3 min. B 90 % > 6 min. B 100 % 10 min. B 100 % > 10.1 min. B 75 % M conditions (LCM-8050) Ionization EI, ositive MRM mode 3

Table 3 MRM Transition Compound recursor ion ion Compound recursor ion ion ABG-I 391.4 271.3 GALC-I 417.4 ABG-* 384.3 GALC- 412.4 ABG- 546.4 264.2 GALC- 574.5 264.25 AM-I 405.4 GLA-I 489.3 389.3 AM- 398.4 GLA- 489.3 384.2 AM- 563.4 184.1 GLA- 646.4 546.25 GAA-I 503.3 403.3 IDUA-I 431.3 322.2 GAA- 498.3 398.2 IDUA- 426.2 317.2 GAA- 660.4 560.25 IDUA- 602.3 317.2 * means product Result In Japan, when newborn screening of lysosomal storage disease using LC-M/M is implemented, it is necessary to perform validation of the analysis method. The FIA method has been developed as the analysis method of 6-plex using tandem mass spectrometer. We evaluated both analysis method of FIA and on-column. 4

Results of FIA method sample 1 (Blank) sample 2 (Normal) 1:ABG_I 391.40>271.30(+) CE: -2 1:ABG_I 391.40>271.30(+) CE: -2 ABG 2:ABG_ 384.30>0(+) CE: -2 2:ABG_ 384.30>0(+) CE: -2 3:AM_I 405.40>0(+) CE: -3 3:AM_I 405.40>0(+) CE: -3 AM (x1,000) 7.5 4:AM_ 398.40>0(+) CE: -3 4:AM_ 398.40>0(+) CE: -3 GAA 11:GAA_I 503.30>403.30(+) CE: -1 1.5 (x1,000) 12:GAA_ 498.30>398.20(+) CE: -1 11:GAA_I 503.30>403.30(+) CE: -1 12:GAA_ 498.30>398.20(+) CE: -1 0.1 0.2 0.3 0.4 min 0.1 0.2 0.3 0.4 min 5:GALC_I 417.40>0(+) CE: -2 3.0 5:GALC_I 417.40>0(+) CE: -2 3.0 GALC 6:GALC_ 412.40>0(+) CE: -2 3.0 6:GALC_ 412.40>0(+) CE: -2 0.1 0.2 0.3 0.4 min 0.1 0.2 0.3 0.4 min GLA 1.5 9:GLA_I 489.30>389.30(+) CE: -1 10:GLA_ 484.30>384.20(+) CE: -1 9:GLA_I 489.30>389.30(+) CE: -1 1.5 10:GLA_ 484.30>384.20(+) CE: -1 7:IDUA_I 431.30>322.20(+) CE: -17.0 7:IDUA_I 431.30>322.20(+) CE: -17.0 IDUA (x1,000) 8:IDUA_ 426.20>317.20(+) CE: -17.0 8:IDUA_ 426.20>317.20(+) CE: -17.0 Figure 3 Results of FIA method; MRM chromatograms of each target compound ample #1 (Blank): sample containing no blood; ample #2 (Normal): ample containing enzymes with all activities All peaks were clearly detected for enzyme decomposition products in ample #1 and repeatability of measurement was good (data not shown). These results were indicated to be able to distinguish sample #1 and sample #2 in all enzyme activity data. However, all data in sample #1, especially ABG, GALC, GLA, showed significant peaks in their product chromatograms. 5

Result of on-column method Then, an analysis using on-column separation was used to confirm the reason of the peak in product MRMs of the blank sample. In this analysis, 3 MRMs,, and ubstrate, were monitored. The result are shown in Figure 4. ABG 1:ABG_I 391.40>271.30(+) CE: -2 AM 1.5 4:AM_I 405.40>0(+) CE: -3 I 2:ABG_ 384.30>0(+) CE: -2 5:AM_ 398.40>0(+) CE: -3 3:ABG_ 546.40>264.20(+) CE: -29.0 (x10,000,000) 6:AM_ 563.40>184.10(+) CE: -2 ubstrate 7.5 1 min GAA 16:GAA_I 503.30>403.30(+) CE: -1 I GALC 7:GALC_I 417.40>0(+) CE: -2 I 17:GAA_ 498.30>398.20(+) CE: -1 8:GALC_ 412.40>0(+) CE: -2 3.0 18:GAA_ 660.40>560.25(+) CE: -2 (x10,000,000) 9:GALC_ 574.50>264.25(+) CE: -3 7.5 1 min GLA 13:GLA_I 489.30>389.30(+) CE: -1 I IDUA 10:IDUA_I 431.30>322.20(+) CE: -17.0 I 14:GLA_ 484.30>384.20(+) CE: -1 3.0 11:IDUA_ 426.20>317.20(+) CE: -17.0 15:GLA_ 646.40>546.25(+) CE: -2 3.0 12:IDUA_ 602.30>317.20(+) CE: -2 7.5 1 min Figure 4 Results of on-column method; MRM chromatograms of each target compound ample #2 (Normal) was analyzed. In MRM chromatograms of ABG, GAA, GALC and GLA products, interfering peaks at the same retention time as those of substrates were found (red arrow in Figure 4). This peaks were probably produced by in-source fragmentation of the substrates. ince these peaks could not be chromatographically separated from enzymatic reaction products in FIA method, they were creating a peak detected even without enzyme activity. In the case of AM, the interfering peak observed (blue arrow) is probably due to in-source fragmentation of GALC I or GALC product. 6

Conclusions Measurement of six enzymatic activities in DB (6-plex assay) by FIA and on column method was conducted by LCM-8050 system. FIA method had higher throughput than with column separation, but it is expected to be less precise and accurate. Acknowledgement oster presenters thank Dr. Osamu Ohara and Dr. Kazuhiro ato (Kazusa DNA Research Institute) for measurements and data analysis. Disclaimer: himadzu LCM-8050 and Nexera M system are intended for Research Use Only (RUO). Not for use in diagnostic procedures. First Edition: June, 2017 himadzu Corporation, 2017